Local drug maker Renata has shipped initial consignment of its first registered product in Australia.
In a statement on Sunday, the company said the shipment of Levonorgestrel known by its brand name Novella-1 in a regulated market like Australia is a testament to their products’ global standard.
Levonorgestrel is approved by the World Health Organisation, and other regulatory bodies such as the US FDA and the Therapeutic
Goods Administration (TGA) as a first line oral emergency contraceptive pill.
The distribution and commercialisation of Levonorgestrel will be done through Renata’s partner, Nova Pharmaceuticals Australasia Pty Ltd, a supplier of pharmaceutical products to pharmacies and supermarkets in Australia.
The commercial launch of Levonorgestrel, with two other products in queue for registration in Australia, would further bolster Renata’s growing market access worldwide, the company also said in the statement.
Source: The Business Standard